TrialJournal of the National Cancer Institute2017

Intrinsic Subtype and Therapeutic Response Among HER2-Positive Breaty st Tumors from the NCCTG (Alliance) N9831 Trial.

Edith A Perez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.